We are live on ! Find out more
SSA

Schonfeld Strategic Advisors Portfolio holdings

AUM $14.2B
1-Year Est. Return 37.17%
This Fund
S&P 500
This Quarter Est. Return
+7.81%
1 Year Est. Return
+37.17%
3 Year Est. Return
+107.75%
5 Year Est. Return
+136.39%
10 Year Est. Return
+833.52%
AUM
$1.1B
AUM Growth
+$125M
Cap. Flow
+$212M
Cap. Flow %
19.38%
Top 10 Hldgs %
12.74%
Holding
889
New
297
Increased
127
Reduced
136
Closed
325

Sector Composition

Rank Sector Weight
1 Healthcare 22.91%
2 Consumer Discretionary 18.04%
3 Industrials 17.71%
4 Financials 7.46%
5 Technology 7.13%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IPXL
51
DELISTED
Impax Laboratories, Inc.
IPXL
$5.67M 0.52%
279,116
+4,892
+2% +$93.5K
SIEN
52
DELISTED
Sientra, Inc.
SIEN
$5.66M 0.52%
36,770
+1,000
+3% +$117K
AAAP
53
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$5.57M 0.51%
82,341
+32,341
+65% +$1.57M
IDXX icon
54
Idexx Laboratories
IDXX
$43.9B
$5.56M 0.51%
35,762
+33,664
+1,605% +$5.32M
DGX icon
55
Quest Diagnostics
DGX
$25.6B
$5.54M 0.51%
59,186
+43,310
+273% +$4.6M
PEP icon
56
PepsiCo
PEP
$191B
$5.52M 0.5%
+49,504
New +$5.72M
PVH icon
57
PVH
PVH
$3.87B
$5.51M 0.5%
43,713
+41,056
+1,545% +$5M
ZGNX
58
DELISTED
Zogenix, Inc.
ZGNX
$5.45M 0.5%
+155,422
New +$2.11M
CRL icon
59
Charles River Laboratories
CRL
$10.8B
$5.4M 0.49%
50,000
-5,747
-10% -$590K
XLRN
60
DELISTED
Acceleron Pharma
XLRN
$5.38M 0.49%
+144,017
New +$5M
VRTX icon
61
Vertex Pharmaceuticals
VRTX
$122B
$5.36M 0.49%
35,270
+33,035
+1,478% +$4.97M
HSKA
62
DELISTED
Heska Corp
HSKA
$5.36M 0.49%
60,845
+5,817
+11% +$572K
ISRG icon
63
Intuitive Surgical
ISRG
$128B
$5.31M 0.49%
45,729
+9,729
+27% +$1.06M
SO icon
64
Southern Company
SO
$109B
$5.2M 0.47%
+105,793
New +$5.13M
ARMK icon
65
Aramark
ARMK
$15.2B
$5.11M 0.47%
+174,173
New +$5.05M
ITW icon
66
Illinois Tool Works
ITW
$81.9B
$4.88M 0.45%
+33,000
New +$4.69M
GPK icon
67
Graphic Packaging
GPK
$3.3B
$4.87M 0.44%
+348,892
New +$4.68M
RRGB icon
68
Red Robin
RRGB
$136M
$4.85M 0.44%
+72,373
New +$4.4M
DXCM icon
69
DexCom
DXCM
$28.3B
$4.73M 0.43%
386,360
+175,116
+83% +$3.1M
APD icon
70
Air Products & Chemicals
APD
$65.2B
$4.71M 0.43%
31,166
+19,655
+171% +$2.88M
FE icon
71
FirstEnergy
FE
$28.5B
$4.7M 0.43%
+152,350
New +$4.8M
RGNX icon
72
Regenxbio
RGNX
$622M
$4.62M 0.42%
140,120
+65,120
+87% +$1.47M
NSC icon
73
Norfolk Southern
NSC
$77.1B
$4.61M 0.42%
+34,877
New +$4.24M
BOX icon
74
Box
BOX
$4.18B
$4.48M 0.41%
231,778
+166,718
+256% +$3.13M
UNH icon
75
UnitedHealth
UNH
$379B
$4.48M 0.41%
22,854
+7,752
+51% +$1.5M

Similar funds

Schonfeld Strategic Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Schonfeld Strategic Advisors held 889 positions worth $1.1B, up 13% from $970M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Schonfeld Strategic Advisors deployed $212M of net new capital in Q3 2017, opening 297 new positions and adding to 127 existing holdings. Its largest new stake was First Data Corporation: 819,639 shares worth $14.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 22% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was Athene Holding Ltd. Class A Common Shares, an estimated $17.9M trimmed.

  • Schonfeld Strategic Advisors's largest Q3 2017 buy was First Data Corporation: 819,639 shares worth $14.8M.
  • Schonfeld Strategic Advisors added most to Brightstar Lottery PLC in Q3 2017, an estimated $16.2M increase.
  • Schonfeld Strategic Advisors's biggest Q3 2017 reduction was Athene Holding Ltd. Class A Common Shares, cutting an estimated $17.9M.
  • Schonfeld Strategic Advisors fully exited Invesco QQQ Trust in Q3 2017, selling an estimated $13.8M.
  • Schonfeld Strategic Advisors's ten largest holdings make up 13% of its $1.1B portfolio in Q3 2017.
  • Schonfeld Strategic Advisors opened 297 new positions and closed 325 in Q3 2017.
  • Schonfeld Strategic Advisors's portfolio value rose 13% quarter-over-quarter to $1.1B.

Based on Schonfeld Strategic Advisors's 13F filing for Q3 2017, filed 14 Nov 2017.